Universe Pharmaceuticals Inc (UPC)
2.40
-0.10
(-4.00%)
USD |
NASDAQ |
May 24, 16:00
2.41
+0.01
(+0.42%)
After-Hours: 20:00
Universe Pharmaceuticals Shareholders Equity (Quarterly): 39.53M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 39.53M |
March 31, 2023 | 47.13M |
March 31, 2023 | 47.13M |
September 30, 2022 | 46.44M |
March 31, 2022 | 61.16M |
March 31, 2022 | 61.16M |
September 30, 2021 | 58.93M |
Date | Value |
---|---|
March 31, 2021 | 50.69M |
March 31, 2021 | 50.69M |
September 30, 2020 | 20.80M |
March 31, 2020 | 17.48M |
March 31, 2020 | 17.48M |
September 30, 2019 | 12.38M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
12.38M
Minimum
Sep 2019
61.16M
Maximum
Mar 2022
40.85M
Average
47.13M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
Sinovac Biotech Ltd | 8.709B |
CASI Pharmaceuticals Inc | 15.47M |
Zai Lab Ltd | 762.17M |
Gracell Biotechnologies Inc (DELISTED) | 222.18M |
Adagene Inc | 70.56M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 53.29M |
Total Liabilities (Quarterly) | 13.75M |
Debt to Equity Ratio | 0.1387 |
Current Ratio | 2.676 |
Net Debt Paydown Yield | -10.32% |